Literature DB >> 20492448

1,4-Thienodiazepine-2,5-diones via MCR (I): synthesis, virtual space and p53-Mdm2 activity.

Yijun Huang1, Siglinde Wolf, Michal Bista, Lidio Meireles, Carlos Camacho, Tad A Holak, Alexander Dömling.   

Abstract

1,4-Thienodiazepine-2,5-diones have been synthesized via the Ugi-Deprotection-Cyclization (UDC) approach starting from Gewald 2-aminothiophenes in a convergent and versatile manner. The resulting scaffold is unprecedented, cyclic, and peptidomimetic with four points of diversity introduced from readily available starting materials. In addition to eighteen synthesized and characterized compounds, a virtual compound library was generated and evaluated for chemical space distribution and drug-like properties. A small focused compound library of 1,4-thienodiazepine-2,5-diones has been screened for the activity against p53-Mdm2 interaction. Biological evaluations demonstrated that some compounds exhibited promising antagonistic activity.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20492448      PMCID： PMC2913441          DOI： 10.1111/j.1747-0285.2010.00989.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN： 1747-0277            Impact factor:   2.817


  37 in total

Review 1.  "Multi-component reactions : emerging chemistry in drug discovery" 'from xylocain to crixivan'.

Authors:  Christopher Hulme; Vijay Gore
Journal:  Curr Med Chem       Date:  2003-01       Impact factor: 4.530

2.  NMR indicates that the small molecule RITA does not block p53-MDM2 binding in vitro.

Authors:  Marcin Krajewski; Przemyslaw Ozdowy; Loyola D'Silva; Ulli Rothweiler; Tad A Holak
Journal:  Nat Med       Date:  2005-11       Impact factor: 53.440

3.  Making "real" molecules in virtual space.

Authors:  György Pirok; Nóra Maté; Jeno Varga; József Szegezdi; Miklós Vargyas; Szilard Dórant; Ferenc Csizmadia
Journal:  J Chem Inf Model       Date:  2006 Mar-Apr       Impact factor: 4.956

4.  Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo.

Authors:  Holly K Koblish; Shuyuan Zhao; Carol F Franks; Robert R Donatelli; Rose M Tominovich; Louis V LaFrance; Kristi A Leonard; Joan M Gushue; Daniel J Parks; Raul R Calvo; Karen L Milkiewicz; Juan José Marugán; Pierre Raboisson; Maxwell D Cummings; Bruce L Grasberger; Dana L Johnson; Tianbao Lu; Christopher J Molloy; Anna C Maroney
Journal:  Mol Cancer Ther       Date:  2006-01       Impact factor: 6.261

5.  High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx.

Authors:  Anna Czarna; Grzegorz M Popowicz; Aleksandra Pecak; Siglinde Wolf; Grzegorz Dubin; Tad A Holak
Journal:  Cell Cycle       Date:  2009-04-16       Impact factor: 4.534

6.  Charge distribution from a simple molecular orbital type calculation and non-bonding interaction terms in the force field MAB.

Authors:  P R Gerber
Journal:  J Comput Aided Mol Des       Date:  1998-01       Impact factor: 3.686

7.  MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry.

Authors:  P R Gerber; K Müller
Journal:  J Comput Aided Mol Des       Date:  1995-06       Impact factor: 3.686

Review 8.  Substituted 1,4-benzodiazepine-2,5-diones as alpha-helix mimetic antagonists of the HDM2-p53 protein-protein interaction.

Authors:  Maxwell D Cummings; Carsten Schubert; Daniel J Parks; Raul R Calvo; Louis V LaFrance; Jennifer Lattanze; Karen L Milkiewicz; Tianbao Lu
Journal:  Chem Biol Drug Des       Date:  2006-03       Impact factor: 2.817

9.  Robust NMR screening for lead compounds using tryptophan-containing proteins.

Authors:  Michal Bista; Kaja Kowalska; Weronika Janczyk; Alexander Dömling; Tad A Holak
Journal:  J Am Chem Soc       Date:  2009-06-10       Impact factor: 15.419

10.  Escape from flatland: increasing saturation as an approach to improving clinical success.

Authors:  Frank Lovering; Jack Bikker; Christine Humblet
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446
View more
  24 in total

Review 1.  Chemistry and biology of multicomponent reactions.

Authors:  Alexander Dömling; Wei Wang; Kan Wang
Journal:  Chem Rev       Date:  2012-03-22       Impact factor: 60.622

2.  Exhaustive fluorine scanning toward potent p53-Mdm2 antagonists.

Authors:  Yijun Huang; Siglinde Wolf; David Koes; Grzegorz M Popowicz; Carlos J Camacho; Tad A Holak; Alexander Dömling
Journal:  ChemMedChem       Date:  2011-09-27       Impact factor: 3.466

3.  General one-pot, two-step protocol accessing a range of novel polycyclic heterocycles with high skeletal diversity.

Authors:  Zhigang Xu; Muhammad Ayaz; Alexandra A Cappelli; Christopher Hulme
Journal:  ACS Comb Sci       Date:  2012-07-12       Impact factor: 3.784

4.  EVALUATION OF AROMATIC 6-SUBSTITUTED THIENOPYRIMIDINES AS SCAFFOLDS AGAINST PARASITES THAT CAUSE TRYPANOSOMIASIS, LEISHMANIASIS, AND MALARIA.

Authors:  Jennifer L Woodring; Gautam Patel; Jessey Erath; Ranjan Behera; Patricia J Lee; Susan E Leed; Ana Rodriguez; Richard J Sciotti; Kojo Mensa-Wilmot; Michael P Pollastri
Journal:  Medchemcomm       Date:  2015-02       Impact factor: 3.597

5.  1,4-Thienodiazepine-2,5-diones via MCR (II): scaffold hopping by Gewald and Ugi-deprotection-cyclization strategy.

Authors:  Yijun Huang; Alexander Dömling
Journal:  Chem Biol Drug Des       Date:  2010-06-09       Impact factor: 2.817

6.  Discovery of a Potent Allosteric Kinase Modulator by Combining Computational and Synthetic Methods.

Authors:  Edwin Kroon; Jörg O Schulze; Evelyn Süß; Carlos J Camacho; Ricardo M Biondi; Alexander Dömling
Journal:  Angew Chem Int Ed Engl       Date:  2015-09-04       Impact factor: 15.336

7.  Multicomponent synthesis of diverse 1,4-benzodiazepine scaffolds.

Authors:  Yijun Huang; Kareem Khoury; Tyler Chanas; Alexander Dömling
Journal:  Org Lett       Date:  2012-11-16       Impact factor: 6.005

Review 8.  Privileged diazepine compounds and their emergence as bromodomain inhibitors.

Authors:  Steven G Smith; Roberto Sanchez; Ming-Ming Zhou
Journal:  Chem Biol       Date:  2014-04-17

9.  Series of Alkynyl-Substituted Thienopyrimidines as Inhibitors of Protozoan Parasite Proliferation.

Authors:  Jennifer L Woodring; Ranjan Behera; Amrita Sharma; Justin Wiedeman; Gautam Patel; Baljinder Singh; Paul Guyett; Emanuele Amata; Jessey Erath; Norma Roncal; Erica Penn; Susan E Leed; Ana Rodriguez; Richard J Sciotti; Kojo Mensa-Wilmot; Michael P Pollastri
Journal:  ACS Med Chem Lett       Date:  2018-09-04       Impact factor: 4.345

Review 10.  Targeting p53-MDM2-MDMX loop for cancer therapy.

Authors:  Qi Zhang; Shelya X Zeng; Hua Lu
Journal:  Subcell Biochem       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.